Wave Life Sciences
biotechnology company
WVE Nasdaq
ISIN SG9999014716 SEC CIK 1631574 LEI 54930070006GPKFYZ813
Follow Wave Life Sciences
Weekly email: filings, results
Revenue, last quarter
$13.2M
+72.9% vs same quarter last year
Net income
−$61.9M
−15% vs same quarter last year
EPS, diluted
−$0.30
+6.3% vs same quarter last year
Operating cash flow
−$60.1M
−34.6% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $42.7M | −$204.4M |
| FY24 | $108.3M | −$97M |
| FY23 | $113.3M | −$57.5M |
| FY22 | $3.6M | −$161.8M |
| FY21 | $41M | −$122.2M |
| FY20 | $20.1M | −$149.9M |
| FY19 | $16M | −$193.6M |
| FY18 | $14.4M | −$146.7M |
| FY17 | $3.9M | −$102M |
| FY16 | $1.1M | −$55.7M |
| FY15 | $152K | −$19.2M |
| FY14 | - | −$5.2M |
| FY13 | - | −$3.3M |
| FY12 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | −504.1% | −478.4% |
| FY24 | −101.9% | −89.6% |
| FY23 | −60% | −50.7% |
| FY22 | −4459.3% | −4434.1% |
| FY21 | −310.1% | −298.3% |
| FY20 | −763.9% | −746.7% |
| FY19 | −1303.4% | −1211.5% |
| FY18 | −1106.7% | −1017.4% |
| FY17 | −2630.1% | −2619.6% |
| FY16 | −5102.6% | −5097.1% |
| FY15 | −12696.1% | −12631.6% |
| FY14 | - | - |
| FY13 | - | - |
| FY12 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$188.2M |
| FY24 | −$152M |
| FY23 | −$20.5M |
| FY22 | −$129.1M |
| FY21 | −$89.6M |
| FY20 | −$117.3M |
| FY19 | −$192.1M |
| FY18 | −$32.8M |
| FY17 | −$102.6M |
| FY16 | −$37.5M |
| FY15 | −$14.4M |
| FY14 | −$5M |
| FY13 | −$3.6M |
| FY12 | - |
- Wave Life Sciences
- Healthcare median
Show the numbers
| Year | Wave Life Sciences | Healthcare median |
|---|---|---|
| FY25 | −478.4% | −30.6% |
| FY24 | −89.6% | −47% |
| FY23 | −50.7% | −58% |
| FY22 | −4434.1% | −80.4% |
| FY21 | −298.3% | −71.8% |
| FY20 | −746.7% | −62.2% |
| FY19 | −1211.5% | −46.2% |
| FY18 | −1017.4% | −49.6% |
| FY17 | −2619.6% | −45.9% |
| FY16 | −5097.1% | −36% |
| FY15 | −12631.6% | −37.8% |
| FY14 | - | −35.5% |
| FY13 | - | −37.1% |
| FY12 | - | −29.1% |